Aehr Test Systems $AEHR Shares Sold by Belpointe Asset Management LLC

Key Points

• Belpointe Asset Management cut its Aehr Test Systems stake by 64.8% in the second quarter, selling 7,892 shares and retaining 4,289 shares valued at approximately $412,000. Institutional investors and hedge funds collectively own 69.69% of AEHR.
• Analysts remain broadly bullish, with a consensus “Buy” rating and an average price target of $136.67; Jefferies initiated coverage with a $175 target, while other firms set targets between $110 and $125.
• AEHR shares opened at $134.06 after a sharp rally, but insider selling—including the CEO’s sale of 40,000 shares for about $5.2 million—may add pressure. The company’s outlook is supported by a $22 million AI-related follow-on order, record bookings of $60.7 million and a backlog of roughly $100.6 million.

Belpointe Asset Management LLC decreased its holdings in shares of Aehr Test Systems (NASDAQ:AEHR - Free Report) by 64.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,289 shares of the semiconductor company's stock after selling 7,892 shares during the quarter. Belpointe Asset Management LLC's holdings in Aehr Test Systems were worth $412,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of AEHR. Royal Bank of Canada grew its position in shares of Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company's stock valued at $365,000 after purchasing an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Aehr Test Systems by 8.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company's stock worth $126,000 after purchasing an additional 1,344 shares during the period. JPMorgan Chase & Co. raised its stake in Aehr Test Systems by 7.9% during the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company's stock worth $201,000 after purchasing an additional 1,145 shares during the period. Legal & General Group Plc boosted its holdings in Aehr Test Systems by 110.8% in the 2nd quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company's stock valued at $89,000 after purchasing an additional 3,617 shares during the last quarter. Finally, Rhumbline Advisers boosted its holdings in Aehr Test Systems by 3.1% in the 2nd quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company's stock valued at $536,000 after purchasing an additional 1,254 shares during the last quarter. 69.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on AEHR. Wall Street Zen upgraded Aehr Test Systems from a "sell" rating to a "hold" rating in a report on Saturday, July 18th. Jefferies Financial Group initiated coverage on Aehr Test Systems in a research note on Thursday. They set a "buy" rating and a $175.00 target price for the company. Lake Street Capital restated a "buy" rating and issued a $110.00 target price on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Craig Hallum reaffirmed a "buy" rating and issued a $125.00 price target on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Finally, Zacks Research upgraded Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a report on Friday, July 17th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $136.67.

Insider Activity

In other news, CEO Gayn Erickson sold 40,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $130.84, for a total value of $5,233,600.00. Following the completion of the sale, the chief executive officer directly owned 157,723 shares of the company's stock, valued at $20,636,477.32. This trade represents a 20.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rhea J. Posedel sold 8,413 shares of the stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $130.00, for a total value of $1,093,690.00. Following the completion of the transaction, the director owned 387,962 shares of the company's stock, valued at $50,435,060. The trade was a 2.12% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 109,475 shares of company stock valued at $13,827,160 over the last ninety days. 6.80% of the stock is currently owned by company insiders.

Key Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1x1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Aehr Test Systems Stock Up 8.7%

AEHR opened at $134.06 on Friday. Aehr Test Systems has a 52 week low of $16.38 and a 52 week high of $147.40. The business has a 50 day moving average price of $92.83 and a two-hundred day moving average price of $71.45. The company has a market cap of $4.37 billion, a PE ratio of -558.56 and a beta of 3.10.

Aehr Test Systems Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source